KITE PHARMA INC's ticker is and the CUSIP is 49803L959. A total of 3 filers reported holding KITE PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $24,077,000 | +49.0% | 133,900 | -14.1% | 0.22% | +30.4% |
| Q2 2017 | $16,162,000 | +122.4% | 155,900 | +68.4% | 0.17% | +97.6% |
| Q1 2017 | $7,268,000 | +731.6% | 92,600 | +374.9% | 0.08% | +962.5% |
| Q4 2016 | $874,000 | -79.2% | 19,500 | -74.0% | 0.01% | -82.6% |
| Q3 2016 | $4,195,000 | +853.4% | 75,100 | +753.4% | 0.05% | +820.0% |
| Q2 2016 | $440,000 | +3042.9% | 8,800 | +2833.3% | 0.01% | – |
| Q1 2016 | $14,000 | -98.2% | 300 | -97.6% | 0.00% | -100.0% |
| Q4 2015 | $776,000 | -38.3% | 12,600 | -44.2% | 0.01% | -47.1% |
| Q3 2015 | $1,258,000 | +20.6% | 22,600 | +32.2% | 0.02% | +13.3% |
| Q2 2015 | $1,043,000 | -42.2% | 17,100 | -45.4% | 0.02% | -46.4% |
| Q1 2015 | $1,805,000 | +169.8% | 31,300 | +169.8% | 0.03% | +180.0% |
| Q4 2014 | $669,000 | – | 11,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 291 | $1,305,000 | 0.08% |
| SIMPLEX TRADING, LLC | 192 | $150,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 19,500 | $874,000 | 0.01% |